Borregaard ASA
BRGAY
Other OTC35.15
USD
- -
- -
ISIN
US1000192070
CUSIP
100019207
Return %
Stock
S&P500
1Y
- -
19.43
3Y
16.01
76.01
5Y
135.91
74.94
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Tom Erik Foss-Jacobsen
- Full Time Employees
- 1,228
- Sector
- Basic Materials
- Industry
- Chemicals
- Address
- PO Box 162 Sarpsborg OE Norway 1701
- IPO Date
- Apr 6, 2016
- Website
- borregaard.com
- Similar Companies
- Business
- Borregaard ASA is a Norway-based biorefinery and specialty chemicals company founded in 2012 and headquartered in Sarpsborg, Norway. The company develops, produces, and markets advanced and sustainable biochemicals and biomaterials derived from renewable raw materials. Its main product portfolio includes lignin-based biopolymers and biovanillin used in agrochemicals, batteries, industrial binders, and construction; specialty cellulose used as raw material for cellulose ethers and cellulose acetate; cellulose fibrils; fine chemicals including pharmaceutical intermediates and water-free bioethanol with an annual production capacity of 20 million liters; and other bio-based solutions supporting various industrial applications. Borregaard serves a global customer base across Europe, Asia, and other regions through three business segments: BioSolutions, BioMaterials, and Fine Chemicals. In recent years, Borregaard has focused on strategic expansion and specialization, including investments to reduce CO2 emissions, improve energy efficiency, and increase production capacity by 5-10% expected from mid-2026. The company participates actively in capital raising for allied marine biotech firms and has entered partnerships and convertible loan agreements to support innovative growth opportunities. Operational changes include specialization projects within BioSolutions and temporary production disruptions in specialty cellulose production while prioritizing higher-margin applications. Borregaard also reinforces a commitment to sustainability, with ongoing initiatives to reduce carbon footprint and enhance renewable product offerings. These efforts have supported a stable EBITDA performance around NOK 1.8 billion in 2024 despite macroeconomic challenges, with ongoing investments aimed at strengthening competitive advantages and improving facility flexibility. Borregaard operates primarily in the specialty chemicals and biomaterials industry, targeting customers in agriculture, pharmaceuticals, construction, food and beverages, and industrial manufacturing. The company’s unique wood-based sulphite pulping process, protected by intellectual property rights, underpins its competitive position in producing sustainable bio-based chemicals and materials. Borregaard maintains a strong financial profile with active risk management and a focus on sustainable value growth while expanding its footprint in global markets through organic growth and selective strategic investments. Borregaard ASA is publicly listed on the Oslo Stock Exchange under the ticker BRG and has an unsponsored American Depositary Receipt (ADR) program trading under BRGAY in the U.S. The company maintains high operational and environmental standards in line with its strategy to be a leading provider of sustainable biochemicals and biomaterials globally. This comprehensive description integrates Borregaard's core products and services, recent strategic and operational developments, industry positioning, geographic scope, and financial framework as of late 2025.
Borregaard ASA (BRGAY) Q2 2026 Earnings Call Transcript
Borregaard ASA (BRGAY) Discusses BioSolutions Outlook, Market Uncertainty, and Product Mix Ahead of Q2 Close Transcript